Learn

Three Infusions in Twelve Weeks: A Toronto Pain Trial Ran a Very Different Protocol

A Toronto trial paired ketamine with structured therapy for chronic nerve pain. It used three infusions over twelve weeks, not six over three.

4 Best Ketamine Clinics in Tacoma, WA (2026) — Verified & Reviewed

Most of Tacoma’s ketamine infrastructure sits on a single street: the region’s most experienced infusion practice and its widest-menu interventional psychiatry clinic both operate on South Union Avenue, four blocks apart. The four providers ranked here hold verified listings in the HealingMaps Washington directory, and that per-clinic detail drives the rankings; the pricing context around […]

4 Best Ketamine Clinics in Provo (2026) — Verified & Reviewed

A ketamine patient in Provo is choosing among three care models more than among neighborhoods: a national interventional psychiatry office downtown, homegrown Utah County programs built around ketamine-assisted psychotherapy, and a flat-rate infusion clinic thirty minutes up I-15. Every provider ranked below is documented in a verified HealingMaps directory listing, while the surrounding cost context […]

There Are Now Clinics for People Harmed by Psychedelics. Here Is Where They Are

Johns Hopkins opened the first US clinic for lasting psychedelic side effects. Where the clinics are, what they treat, what recovery looks like, and what to do meanwhile.

A Meditation Retreat Produced Psychedelic-Like Brain Changes. Here Is What the Study Actually Shows

A study is circulating with a striking claim. Seven days at a meditation retreat, no drugs involved, and participants’ brains showed connectivity patterns resembling those seen under psychedelics. The measurements are real. Nearly every headline about them is describing something the study did not do. New competition is a margin problem before it is a […]

An Oral LSD Tablet Has Now Cleared Phase 3 Twice This Year. Here Is What Comes Next

Editor’s note (September 16, 2026): DT120 has since cleared a third Phase 3 trial. We covered the Panorama results and the low-dose arm designed to address unblinding. An oral LSD tablet has now cleared phase 3 twice in a single year. Definium Therapeutics reported that DT120 ODT met its primary endpoint in generalized anxiety disorder, […]

MAPS-Funded MDMA Therapy for PTSD Is Back at the FDA, Without a New Phase 3 Trial

MDMA assisted therapy for PTSD appears to be back in front of the FDA. Psychedelic Alpha reported on August 9 that Resilient Pharmaceuticals has resubmitted the application the agency declined two years ago. MAPS responded to that report the next day without independently confirming it. The detail that matters is not the resubmission. It is […]

IV Ketamine Could Get Its First FDA Psychiatric Indication. Here Is What Would Actually Change

Last reviewed and updated: August 13, 2026. Headlines about the FDA and ketamine will multiply this year. Most operators will read them wrong. Some describe a generic manufacturing application. One concerns NRX-100, a specific IV ketamine product pursuing a psychiatric indication. That program could change how clinics approach coverage, marketing and protocols. Knowing which is […]

England Has a Recreational Ketamine Crisis. Here Is How American Clinics Keep It From Happening Here

In one Manchester treatment cohort, 64 percent of the people being treated for ketamine problems were under 18. Forty two percent were between 13 and 16. That is what a recreational ketamine crisis looks like once it has fully arrived, and England is living in one. America is not, and the reason has less to […]

Psilocybin Sessions for PTSD Are Mostly Silent. The Argument About What to Call Them Is Not

A new analysis found psilocybin dosing sessions for PTSD are silent 78 percent of the time. Why the authors want the name changed, and who benefits if it is.